Purified human fibroblast interferon in vivo: skin reactions and effect on bone marrow precursor cells.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Cancer Letters

• Publication date

  1979-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0304-3835(79)80050-6PMID 509407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast interferon treatment of a patient with chronic active hepatitis. Increased number of circulating T lymphocytes and elimination of rosette-inhibitory factor.

  1979cited by this paper
• Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro.

  1978cited by this paper
• Aging in vitro and large-scale interferon production by 15 new strains of human diploid fibroblasts

  1978cited by this paper
• Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.

  1978cited by this paper
• Antiproliferative activity of highly purified mouse interferon: brief communication.

  1978cited by this paper
• Production and preparation of human leukocyte interferon

  1977cited by this paper
• [Toxicity of human leucocyte interferon preparations in human bone-marrow cultures].

  1977cited by this paper
• Interferon-induced skin reactivity in man.

  1977cited by this paper
• Cytotoxic effects of interferon in vitro on granulocytic progenitor cells.

  1977cited by this paper
• An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic acid-polycytidylic acid and its mismatched analogues.

  1976cited by this paper
• Binding of human fibroblast interferon to concanavalin A-agarose. Involvement of carbohydrate recognition and hydrophobic interaction.

  1976cited by this paper
• Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.

  1976cited by this paper
• T CELLS, B CELLS, AND HL-A8 IN CHRONIC ACTIVE HEPATITIS

  1975cited by this paper
• Letter: T cells, B cells, and HL-A8 in chronic active hepatitis.

  1975cited by this paper
• Spontaneous interferon production and Epstein-Barr virus antigen expression in human lymphoid cell lines.

  1975cited by this paper
• The colony-forming cell in the normal and leukemia human host: responses to streptovaricin and rifamycin SV.

  1974cited by this paper
• Clinical and laboratory investigations on man: systemic administration of potent interferon to man.

  1973cited by this paper
• In vitro colony formation by normal and leukemic human hematopoietic cells: interaction between colony-forming and colony-stimulating cells.

  1973cited by this paper
• Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes.

  1972cited by this paper

• Interferon therapy: Pharmacokinetic and pharmacological aspects

  2005cites this paper
• Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.

  1988cites this paper
• Human nasal mucosal responses to topically applied recombinant leukocyte A interferon.

  1987cites this paper
• Interferon-βser As Prophylaxis Against Experimental Rhinovirus Infection in Volunteers

  1986cites this paper
• Interferon-Induced Growth Modulation: Low Dose Maintenance of the Antiproliferative Response

  1984cites this paper
• Purification and characterization of murine and human interferons. A review of the literature of the 1970s.

  1982cites this paper
• Effect of human fibroblast interferon (INF-beta) on hepatitis B virus DNA in serum.

  1982cites this paper
• Human interferon: Pharmacokinetics and antiviral chemotherapy

  1982cites this paper
• Production and preparation of human fibroblast interferon for clinical trials.

  1981cites this paper
• AUGMENTATION OF HUMAN NATURAL KILLER CELL ACTIVITY BY PURIFIED INTERFERON AND POLYRIBONUCLEOTIDES1

  1980cites this paper
• Skin Reactions to Interferon Inoculations are Reduced but Not Abolished by Purification

  1980cites this paper
• Production, purification and clinical application of human fibroblast interferon.

  1980cites this paper
• Interferon, preclinical basis for clinical trials with fibroblast interferon in Japan.

  1980cites this paper
• Interferons: rationale for clinical trials in neoplastic disease.

  1979cites this paper
• Fibroblast interferon treatment of a patient with chronic active hepatitis. Increased number of circulating T lymphocytes and elimination of rosette-inhibitory factor.

  1979cites this paper